Oaktree Acquisition Corp. III Life Sciences OACC
Nasdaq · stock · Blank Checks · IPO 2024-12-16
Oaktree Acquisition Corp. III Life Sciences statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Key ratios (by fiscal year)
| Ratio | FY2025 |
|---|---|
| Return on assets | 3.6% |
| Return on equity | -107.7% |
| Current ratio | 1.19 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.